MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?

MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?

MRI-detected T3a prostate cancer is a heterogeneous disease. This post-hoc analysis of a prospective trial found that patients with T3a disease presenting obliteration of the recto-prostatic angle, contact-asymmetry of neuro-vascular bundle and periprostatic fat invasion, may be at higher risk of bi...

Full description

Bibliographic Details
Main Authors: A. Gomez-Iturriaga, D. Büchser, I. San Miguel, M. Marban, A. Urresola, A. Ezquerro, A. Gil, F. Suarez, A. Gonzalez, E. Mairata, L. Martinez-Indart, J. Cacicedo, F. Couñago, P. Mínguez, F. Casquero
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Prostate cancer
Radiotherapy
Multiparametric MRI
Extraprostatic extension
Biochemical failure
Metastases
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630820300689

Internet

http://www.sciencedirect.com/science/article/pii/S2405630820300689

Similar Items